| Gene Symbol | FGF12 |
| Entrez ID | 2257 |
| Uniprot ID | P61328 |
| Description | fibroblast growth factor 12 |
| Chromosomal Location | chr3: 192,139,395-192,767,764 |
| Ontology | GO ID | GO Term | Definition | Evidence |
|---|---|---|---|---|
|
BP |
GO:0003254 |
regulation of membrane depolarization |
Any process that modulates the rate, frequency or extent of membrane depolarization. Membrane depolarization is the process in which membrane potential changes in the depolarizing direction from the resting potential, usually from negative to positive. |
IEA |
|
BP |
GO:0007165 |
signal transduction |
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
TAS |
|
BP |
GO:0007267 |
cell-cell signaling |
Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions. |
TAS |
|
BP |
GO:0007268 |
chemical synaptic transmission |
The vesicular release of classical neurotransmitter molecules from a neuron, across a chemical synapse, the subsequent activation of neurotransmitter receptors of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse. |
IEA |
|
BP |
GO:0007399 |
nervous system development |
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state. |
TAS |
|
BP |
GO:0007507 |
heart development |
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood. |
TAS |
|
BP |
GO:0008344 |
adult locomotory behavior |
Locomotory behavior in a fully developed and mature organism. |
IEA |
|
BP |
GO:0008543 |
fibroblast growth factor receptor signaling pathway |
The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands. |
IEA |
|
BP |
GO:0010765 |
positive regulation of sodium ion transport |
Any process that increases the frequency, rate or extent of the directed movement of sodium ions (Na+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
IEA |
|
BP |
GO:0050905 |
neuromuscular process |
Any process pertaining to the functions of the nervous and muscular systems of an organism. |
IEA |
|
BP |
GO:0086002 |
cardiac muscle cell action potential involved in contraction |
An action potential that occurs in a cardiac muscle cell and is involved in its contraction. |
NAS |
|
BP |
GO:0098908 |
regulation of neuronal action potential |
Any process that modulates the frequency, rate or extent of action potential creation, propagation or termination in a neuron. This typically occurs via modulation of the activity or expression of voltage-gated ion channels. |
IMP |
|
BP |
GO:1902305 |
regulation of sodium ion transmembrane transport |
Any process that modulates the frequency, rate or extent of sodium ion transmembrane transport. |
ISS |
|
BP |
GO:1905150 |
regulation of voltage-gated sodium channel activity |
Any process that modulates the frequency, rate or extent of voltage-gated sodium channel activity. |
IMP |
|
BP |
GO:2000649 |
regulation of sodium ion transmembrane transporter activity |
Any process that modulates the frequency, rate or extent of sodium ion transmembrane transporter activity. |
ISS |
|
BP |
GO:2001258 |
negative regulation of cation channel activity |
Any process that stops, prevents or reduces the frequency, rate or extent of cation channel activity. |
IEA |
|
CC |
GO:0005615 |
extracellular space |
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
TAS |
|
CC |
GO:0005634 |
nucleus |
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
IDA |
|
MF |
GO:0008083 |
growth factor activity |
The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation. |
IEA |
|
MF |
GO:0017080 |
sodium channel regulator activity |
Modulates the activity of a sodium channel. |
ISS |
|
MF |
GO:0044325 |
ion channel binding |
Interacting selectively and non-covalently with one or more specific sites on an ion channel, a protein complex that spans a membrane and forms a water-filled channel across the phospholipid bilayer allowing selective ion transport down its electrochemical gradient. |
ISS |
| Domain ID | Description |
|---|---|
|
IPR002209 |
Fibroblast growth factor family |
|
IPR008996 |
Cytokine IL1/FGF |
|
IPR028254 |
Fibroblast growth factor 12 |
| Pathway ID | Pathway Term | Pathway Source |
|---|---|---|
|
hsa04010 |
MAPK signaling pathway |
KEGG |
|
hsa04014 |
Ras signaling pathway |
KEGG |
|
hsa04015 |
Rap1 signaling pathway |
KEGG |
|
hsa04151 |
PI3K-Akt signaling pathway |
KEGG |
|
hsa04810 |
Regulation of actin cytoskeleton |
KEGG |
|
hsa05200 |
Pathways in cancer |
KEGG |
|
hsa05218 |
Melanoma |
KEGG |
|
hsa05224 |
Breast cancer |
KEGG |
|
WP51 |
Regulation of Actin Cytoskeleton |
WikiPathways |
|
WP3931 |
ESC Pluripotency Pathways |
WikiPathways |
|
WP3932 |
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway |
WikiPathways |
| Pubmed ID | Author | Year | Title |
|---|---|---|---|
|
12734205 |
Wood et al. |
2003 |
The Molecular Phenotype of Polycystic Ovary Syndrome (PCOS) Theca Cells and New Candidate PCOS Genes Defined by Microarray Analysis |
|
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
| Gene Symbol | Entrez ID | Uniprot ID | Score |
|---|---|---|---|
|
FGFR1 |
2260 |
P11362 |
0.00 |
|
FGFR3 |
2261 |
P22607 |
0.00 |
|
FGFR4 |
2264 |
P22455 |
0.00 |
|
PDGFRA |
5156 |
P16234 |
0.00 |
|
COIL |
8161 |
P38432 |
0.63 |
|
IKZF1 |
10320 |
Q13422 |
0.63 |
|
ZNF460 |
10794 |
Q14592 |
0.63 |
|
LZTS2 |
84445 |
Q9BRK4 |
0.63 |
|
APP |
351 |
P05067 |
0.66 |
|
SRPK1 |
6732 |
Q96SB4 |
0.70 |
|
NEDD4 |
4734 |
P46934 |
0.56 |
|
NEDD4L |
23327 |
Q96PU5 |
0.56 |
|
DACH1 |
1602 |
Q9UI36 |
0.63 |
|
DCTD |
1635 |
P32321 |
0.63 |
|
DPPA2 |
151871 |
Q7Z7J5 |
0.63 |
|
MAPK13 |
5603 |
O15264 |
0.65 |
|
SRPK2 |
6733 |
P78362 |
0.70 |
|
MAPK8IP2 |
23542 |
Q13387 |
0.86 |